3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Immunoglobulin Light-chain Amyloidosis
4
Paraproteinemias
1
Amyloidosis
1
Alzheimer Disease
1
Interventions
Dexamethasone
9
Calcium Dobesilate
7
Bortezomib
5
Melphalan
4
Cyclophosphamide
3
ixazomib
2
Thalidomide
2
Doxycycline
2
dexamethasone acetate
1
dexamethasone 21-phosphate
1
daratumumab
1
carfilzomib
1
birtamimab
1
auricularum
1
Tacrolimus
1
Lenalidomide
1
Etoposide
1
Doxorubicin
1
Cisplatin
1
Bendamustine Hydrochloride
1
Antilymphocyte Serum
1
ARQ 197
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Amyloidosis
×
birtamimab
×
Clear all
NCT02632786
2019-04-05
PRONTO
Prothena Biosciences Ltd.
Phase 2
Completed
129 enrolled
18 charts